Overview of Vitiligo Research October - December 2014
- Vitiligo Screening Tool (VISTO) is a simple, cost-effective, self-administered tool to confirm vitiligo.
- Much lower prevalence of vitiligo and later disease onset among Taiwanese population is reported (0.064%).
- Serum BDNF may be linked to repeatedly reported association of vitiligo with psychiatric disorders.
- Unexpectedly, IL-2 and IL- 6 levels hint at different mechanism of pathogenesis of stress-induced vitiligo.
- Analogue of viral DNA can trigger melanocyte death, which hints at possible contribution of viruses to vitiligo onset.
- Simvastatin is showing potency to reverse and prevent vitiligo in an experimental mouse model.
- Topical latanoprost (prostaglandin F2-alpha analogue) can be used (alone or in combination with NB-UVB phototherapy) to induce repigmentation of vitiligo lesions
- Infrequent topical tacrolimus can be used as prophylactics to prevent relapse after successful repigmentation
- Based on results of study in mice, simvastatin emerges as a novel treatment for vitiligo, capable to prevent vitiligo onset and to reverse already manifested disease
- Ethnical difference in vitiligo prevalence and associated comorbidities profiles has been further confirmed.
- Level of reactive oxygen species in erythrocytes emerges as an indicator of vitiligo activity.
- Involvement of regulatory T-cell abnormalities in vitiligo pathogenesis is gaining more support.
This is a review of research results in the vitiligo field which were indexed in the PubMed database (www.ncbi.nlm.nih.gov/pubmed) for the period from October till December 2014. Retrieved records were manually checked for a relevance to and significance for the field of vitiligo research. Fifty one records were found to be relevant and of interest, and were included into this quarterly overview, under the following sections:
- Reviews & Comments
- Disease Management And Clinical Features
- Quality of life (QoL)
- Vitiligo triggers
- Case reports
- Understanding mechanisms of vitiligo pathogenesis
- Genetic studies
- Candidate biomarkers
- Mechanisms of treatments
- Methodological advancements
- Novel treatment modalities
- Clinical studies and trials
I support the petition to designate June 25 as Vitiligo World Day and save millions of people worldwide from social isolation and persecution.
What is coming?
NY Vitiligo Community Meeting in September
Our next meeting will be on Thursday, September 21st, at 7PM - 8:30PM on the 11th floor of NYU's Ambulatory Care Center at 240 East 38th Street, between 2nd and 3rd Av...21 September 2017 19:00, 11th floor of NYU's Ambulatory Car...
Vitiligo Advocacy Day at the US Capitol
Save-the-Date for the much anticipated Vitiligo Advocacy Day at the United States Capitol this fall. As many of you know, the Advocacy Committee of the Global Vitilig...04 October 2017 10:00, Washington, DC
Who is prone to vitiligo?
Vitiligo affects 0.5-2% of the population, and occurs in all races and all social levels. Vitiligo can affect people of all ages, but often starts between the ages of ...
How to get insurance coverage for vitiligo treatments?
Most of health insurance companies will initially reject claims for vitiligo doctor visits or phototherapy treatments but with enough efforts you can have a substantia...
Is there a traditional medicine to treat vitiligo?
During the last decades, new methods of therapeutic research, ethno-botany and ethno-pharmacology and even archeo-pharmacology (PubMed), have been used extensively to ...
Can chemicals cause vitiligo?
Yes, certain chemicals can, indeed, induce or worsen vitiligo. Most commonly they include phenols, such as 4-tertiary-butyl phenol (4-TBP, found in adhesives) or 4-ter...